Expanding research capacity into neglected tropical diseasesProfessor Paul Kaye from the University of York, whose research team was recently granted €8 million to help Share XExpanding research capacity into neglected tropical diseaseshttps://pharmaphorum.com/r-d/views-analysis-r-d/expanding-research-capacity-into-neglected-tropical-diseases/
Talking vaccines: Industry’s role in protecting the Gavi generationA new report highlights the important work of companies across the industry in boosting access to vaccines worldwide Share XTalking vaccines: Industry’s role in protecting the Gavi generationhttps://pharmaphorum.com/views-analysis-market-access/talking-vaccines-industrys-role-in-protecting-the-gavi-generation/
Coronavirus vaccine: how pharma is picking up the paceThe world is waiting with bated breath for a coronavirus vaccine, which has become one of the most Share XCoronavirus vaccine: how pharma is picking up the pacehttps://pharmaphorum.com/views-analysis-market-access/coronavirus-vaccine-how-pharma-is-picking-up-the-pace/
Sanofi and GSK join forces on coronavirus vaccineAs the world waits with bated breath for a coronavirus vaccine, two of the world’s biggest vaccine manufacturers, Share XSanofi and GSK join forces on coronavirus vaccinehttps://pharmaphorum.com/news/sanofi-and-gsk-join-forces-on-coronavirus-vaccine/
Equal coronavirus vaccine access a “real issue”Though several pharma companies are rushing to produce a vaccine for the coronavirus causing the COVID-19 pandemic, aided Share XEqual coronavirus vaccine access a “real issue”https://pharmaphorum.com/news/equal-coronavirus-vaccine-access-real-issue/
Vaccines trials in the COVID-19 era and tech’s role in speeding studiesOverview The COVID-19 outbreak has exposed the challenges pharmaceutical companies face as they race to develop a coronavirus Share XVaccines trials in the COVID-19 era and tech’s role in speeding studieshttps://pharmaphorum.com/r-d/vaccines-trials-covid-19-coronavirus/
Moderna begins coronavirus vaccine trialThe US biotech Moderna was just about the only stock on the rise yesterday amid the global COVID-19 Share XModerna begins coronavirus vaccine trialhttps://pharmaphorum.com/news/moderna-begins-coronavirus-vaccine-trial/
GSK’s Walmsley gets £2.5m pay rise after strong 2019There can’t be many people in the UK who enjoyed a £2.5 million pay rise this year – Share XGSK’s Walmsley gets £2.5m pay rise after strong 2019https://pharmaphorum.com/news/gsks-walmsley-gets-2-5m-pay-rise-after-strong-sales/
US trials of Gilead’s remdesivir begin against COVID-19 coronavirusThe first US trial of Gilead’s unapproved antiviral remdesivir has officially begun against the novel coronavirus disease COVID-19. Share XUS trials of Gilead’s remdesivir begin against COVID-19 coronavirushttps://pharmaphorum.com/news/us-trials-of-gileads-remdesivir-begin-against-covid-19-coronavirus/
